Related Experiment Video
Updated: May 10, 2026

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin
Published on: December 23, 2010
Leukotriene biosynthesis by polymorphonuclear leukocytes from two patients with chronic granulomatous disease
Abstract:
Polymorphonuclear leukocytes (PMNL) isolated from two patients with chronic granulomatous disease (CGD) were tested for their ability to metabolize arachidonic acid to lipoxygenase products including 5(S),12(R)-dihydroxy-6,14-cis-8,10-trans-eicosatetraenoic acid (LTB4). Analyses of incubations of these PMNL with arachidonic acid and the calcium ionophore A23187 did not differ from simultaneous controls in the production of LTB4, other 5,12-dihydroxy-eicosatetraenoic acids, or monohydroxy-eicosatetraenoic acids. The clinical diagnosis of CGD was confirmed in both cases by determination of PMNL chemiluminescence. Leukocytes from both patients failed to generate active oxygen species in response to either LTB4 or formyl-methionyl-leucyl-phenylalanine. The observation of arachidonic acid oxidation in the absence of superoxide anion precludes a role for the active oxygen species in this metabolic process. These studies clearly dissociate the ionophore-induced leukocyte respiratory burst from the oxidation of arachidonate to the leukotrienes. In addition, the defect of CGD appears to be unrelated to the ability of PMNL to carry out arachidonate oxygenation.
Insights
Chronic granulomatous disease (CGD) patients’ neutrophils can metabolize arachidonic acid to leukotrienes. This process is independent of the superoxide anion, suggesting CGD defects do not impact leukotriene production.
Area of Science:
- Immunology
- Biochemistry
Background:
- Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by impaired function of phagocytes, particularly neutrophils.
- Phagocytes play a crucial role in host defense through the generation of reactive oxygen species and the production of inflammatory mediators like leukotrienes.
Purpose of the Study:
- To investigate the ability of polymorphonuclear leukocytes (PMNL) from CGD patients to metabolize arachidonic acid into lipoxygenase products, specifically leukotriene B4 (LTB4).
- To determine if the impaired respiratory burst in CGD neutrophils affects arachidonic acid oxidation pathways.
Main Methods:
- PMNL were isolated from two CGD patients and healthy controls.
- Incubations with arachidonic acid and the calcium ionophore A23187 were performed.
- Production of LTB4 and other hydroxy-eicosatetraenoic acids was analyzed.
- PMNL chemiluminescence and generation of active oxygen species were assessed.
Main Results:
- PMNL from CGD patients produced LTB4 and other lipoxygenase products at levels comparable to controls.
- The production of these metabolites occurred even in the absence of detectable superoxide anion generation.
- CGD leukocytes failed to generate active oxygen species in response to stimuli, confirming the disease phenotype.
Conclusions:
- The ionophore-induced production of leukotrienes from arachidonic acid is dissociated from the leukocyte respiratory burst and superoxide anion generation.
- The defect in chronic granulomatous disease does not appear to impair the ability of PMNL to oxygenate arachidonic acid to leukotrienes.
More Related Videos
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Inflammation: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

